Home/Filings/4/0001628280-22-015033
4//SEC Filing

Billen Daniel 4

Accession 0001628280-22-015033

CIK 0001600620other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:09 PM ET

Size

7.4 KB

Accession

0001628280-22-015033

Insider Transaction Report

Form 4
Period: 2022-05-18
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-18+14,61214,612 total
    Exercise: $11.45Exp: 2032-05-18Common Stock (14,612 underlying)
  • Award

    Restricted Stock Unit

    2022-05-18+8,7338,733 total
    Common Shares (8,733 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant.
  • [F2]The option vests in twelve equal monthly installments commencing on June 18, 2022.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001837593

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:09 PM ET
Size
7.4 KB